{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:07:01Z","timestamp":1791328021562,"version":"4.3.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T00:00:00Z","timestamp":1190851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9,27]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We determined the number and functional status of CD4+CD25high regulatory T cells (Treg) in blood samples from patients with metastatic carcinoma, and evaluated their sensitivity to a single intravenous infusion of cyclophosphamide. Treg numbers were significantly higher in 49 patients with metastatic cancer (9\u00b72% of CD4+ T cells) compared to 24 healthy donors (7\u00b71%). These cells expressed the transcription factor forkhead box P3 (FoxP3), glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) and intracellular CD152, and demonstrated a suppressive activity in vitro against CD4+CD25\u2013 autologous proliferation. At a single intravenous infusion, cyclophosphamide failed, in association with a non-specific immunotherapy by intratumoral bacille Calmette\u2013Gu\u00e9rin (BCG), to modulate significantly Treg numbers or function. Metastatic cancer is associated with an expansion of peripheral blood CD4+CD25highFoxP3+GITR+CD152+Treg cells whose immunosuppressive properties do not differ from those of healthy subjects. Moreover, cyclophosphamide administration may not represent an optimal therapy to eliminate Treg, which further underlines the need to identify specific agents that would selectively deplete these cells.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2007.03521.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T21:00:37Z","timestamp":1280178037000},"page":"523-530","source":"Crossref","is-referenced-by-count":100,"title":["Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes"],"prefix":"10.1093","volume":"150","author":[{"given":"S","family":"Audia","sequence":"first","affiliation":[{"name":"INSERM, UMR 866, Faculty of Medicine and Pharmacy"},{"name":"Departments of Internal Medicine and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nicolas","sequence":"additional","affiliation":[{"name":"INSERM, UMR 866, Faculty of Medicine and Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cathelin","sequence":"additional","affiliation":[{"name":"INSERM, UMR 866, Faculty of Medicine and Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Larmonier","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Steele Children's Research Centre, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ferrand","sequence":"additional","affiliation":[{"name":"INSERM, U645, EFSB-FC IFR133 University of Franche-Comt\u00e9, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Foucher","sequence":"additional","affiliation":[{"name":"Pulmonary Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fanton","sequence":"additional","affiliation":[{"name":"Pulmonary Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bergoin","sequence":"additional","affiliation":[{"name":"Hematology Laboratory, Hospital du Bocage"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Maynadie","sequence":"additional","affiliation":[{"name":"Hematology Laboratory, Hospital du Bocage"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Arnould","sequence":"additional","affiliation":[{"name":"Department of Pathology, Centre Georges-Francois Leclerc, Dijon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bateman","sequence":"additional","affiliation":[{"name":"Cancer Sciences Division, University of Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Lorcerie","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Solary","sequence":"additional","affiliation":[{"name":"INSERM, UMR 866, Faculty of Medicine and Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Chauffert","sequence":"additional","affiliation":[{"name":"INSERM, UMR 866, Faculty of Medicine and Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bonnotte","sequence":"additional","affiliation":[{"name":"INSERM, UMR 866, Faculty of Medicine and Pharmacy"},{"name":"Departments of Internal Medicine and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,10,23]]},"reference":[{"key":"2022010406283533800_b1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T cells: key controllers of immunologic self-tolerance","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"key":"2022010406283533800_b2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1517\/14712598.2.8.827","article-title":"Immunoregulatory T cells in cancer immunotherapy","volume":"2","author":"Morse","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"2022010406283533800_b3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4049\/jimmunol.167.3.1137","article-title":"Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells","volume":"167","author":"Piccirillo","year":"2001","journal-title":"J Immunol"},{"key":"2022010406283533800_b4","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.4049\/jimmunol.168.9.4272","article-title":"Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation","volume":"168","author":"Woo","year":"2002","journal-title":"J Immunol"},{"key":"2022010406283533800_b5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1084\/jem.184.2.465","article-title":"Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo","volume":"184","author":"Boczkowski","year":"1996","journal-title":"J Exp Med"},{"key":"2022010406283533800_b6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/1097-0215(20000901)87:5<680::AID-IJC10>3.0.CO;2-P","article-title":"Tumor-specific CD4(+) suppressor T-cell clone capable of inhibiting rejection of syngeneic sarcoma in A\/J mice","volume":"87","author":"Fu","year":"2000","journal-title":"Int J Cancer"},{"key":"2022010406283533800_b7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/eji.200324181","article-title":"CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative","volume":"34","author":"Ghiringhelli","year":"2004","journal-title":"Eur J Immunol"},{"key":"2022010406283533800_b8","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1158\/0008-5472.CAN-06-4296","article-title":"Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses","volume":"67","author":"Tuve","year":"2007","journal-title":"Cancer Res"},{"key":"2022010406283533800_b9","first-page":"1","article-title":"Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice","volume":"2","author":"Jones","year":"2002","journal-title":"Cancer Immun"},{"key":"2022010406283533800_b10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00002371-200205000-00003","article-title":"Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes","volume":"25","author":"Tanaka","year":"2002","journal-title":"J Immunother"},{"key":"2022010406283533800_b11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20041130","article-title":"Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells","volume":"200","author":"Turk","year":"2004","journal-title":"J Exp Med"},{"key":"2022010406283533800_b12","first-page":"3128","article-title":"Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody","volume":"59","author":"Onizuka","year":"1999","journal-title":"Cancer Res"},{"key":"2022010406283533800_b13","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","article-title":"Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity","volume":"163","author":"Shimizu","year":"1999","journal-title":"J Immunol"},{"key":"2022010406283533800_b14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1349-7006.2002.tb01337.x","article-title":"Sequential involvement of two distinct CD4+ regulatory T cells during the course of transplantable tumor growth and protection from 3-methylcholanthrene-induced tumorigenesis by CD25-depletion","volume":"93","author":"Tawara","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"2022010406283533800_b15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.194.6.823","article-title":"Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses","volume":"194","author":"Sutmuller","year":"2001","journal-title":"J Exp Med"},{"key":"2022010406283533800_b16","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.4049\/jimmunol.171.11.5931","article-title":"CD4+\/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination","volume":"171","author":"Casares","year":"2003","journal-title":"J Immunol"},{"key":"2022010406283533800_b17","first-page":"4404","article-title":"Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers","volume":"9","author":"Ichihara","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2022010406283533800_b18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.11618","article-title":"CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression","volume":"98","author":"Sasada","year":"2003","journal-title":"Cancer"},{"key":"2022010406283533800_b19","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","article-title":"Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma","volume":"169","author":"Liyanage","year":"2002","journal-title":"J Immunol"},{"key":"2022010406283533800_b20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00002371-200301000-00009","article-title":"CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens","volume":"26","author":"Javia","year":"2003","journal-title":"J Immunother"},{"key":"2022010406283533800_b21","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-04-3232","article-title":"Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma","volume":"65","author":"Ormandy","year":"2005","journal-title":"Cancer Res"},{"key":"2022010406283533800_b22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2003.09.020","article-title":"Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients","volume":"92","author":"Fattorossi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"2022010406283533800_b23","first-page":"4766","article-title":"Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer","volume":"61","author":"Woo","year":"2001","journal-title":"Cancer Res"},{"key":"2022010406283533800_b24","first-page":"606","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2022010406283533800_b25","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"2022010406283533800_b26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"2022010406283533800_b27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25(+)CD4(+) regulatory T cells through G1TR breaks immunological self-tolerance","volume":"3","author":"Shimizu","year":"2002","journal-title":"Nat Immunol"},{"key":"2022010406283533800_b28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"2022010406283533800_b29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"2022010406283533800_b30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients","volume":"56","author":"Ghiringhelli","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"2022010406283533800_b31","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.4049\/jimmunol.173.8.4929","article-title":"MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity","volume":"173","author":"Bonnotte","year":"2004","journal-title":"J Immunol"},{"key":"2022010406283533800_b32","first-page":"8408","article-title":"Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model","volume":"63","author":"Hermans","year":"2003","journal-title":"Cancer Res"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2007.03521.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/150\/3\/523\/42038006\/j.1365-2249.2007.03521.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/150\/3\/523\/42038006\/j.1365-2249.2007.03521.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T09:58:09Z","timestamp":1685699889000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/150\/3\/523\/6457711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,27]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,10,23]]},"published-print":{"date-parts":[[2007,9,27]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03521.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,12]]},"published":{"date-parts":[[2007,9,27]]}}}